BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21677599)

  • 21. The impact of donor and recipient age on the outcome of kidney transplantation.
    Kwon OJ; Lee HG; Kwak JY
    Transplant Proc; 2004 Sep; 36(7):2043-5. PubMed ID: 15518739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: absence of C4d in grafts from non-heart-beating donors.
    Crespo M; Sole M; Arostegui JL; Mila J; Martorell J; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3688-9. PubMed ID: 16386506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.
    Ranjan P; Nada R; Jha V; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 2008 May; 23(5):1735-41. PubMed ID: 18065805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of free radicals: mediated injury occurring in the kidney donor.
    Kosieradzki M; Kuczynska J; Piwowarska J; Wegrowicz-Rebandel I; Kwiatkowski A; Lisik W; Michalak G; Danielewicz R; Paczek L; Rowinski WA
    Transplantation; 2003 Apr; 75(8):1221-7. PubMed ID: 12717206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
    Campbell SB; Hothersall E; Preston J; Brown AM; Hawley CM; Wall D; Griffin AD; Isbel NM; Nicol DL; Johnson DW
    Transplantation; 2003 Nov; 76(10):1452-7. PubMed ID: 14657685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful transplantation of kidneys from deceased donors with acute renal failure: Three-year results.
    Anil Kumar MS; Khan SM; Jaglan S; Heifets M; Moritz MJ; Saeed MI; Fyfe B; Sustento-Reodica N; Kumar A
    Transplantation; 2006 Dec; 82(12):1640-5. PubMed ID: 17198251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation.
    Damman J; Nijboer WN; Schuurs TA; Leuvenink HG; Morariu AM; Tullius SG; van Goor H; Ploeg RJ; Seelen MA
    Nephrol Dial Transplant; 2011 Jul; 26(7):2345-54. PubMed ID: 21127132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the brain-death process on acute rejection in renal transplantation.
    Sánchez-Fructuoso A; Naranjo Garcia P; Calvo Romero N; Ridao N; Naranjo Gómez P; Conesa J; Barrientos A
    Transplant Proc; 2007 Sep; 39(7):2214-6. PubMed ID: 17889141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of gender and age matching for long-term graft survival in living donor renal transplantation.
    Kwon OJ; Kwak JY; Kang CM
    Transplant Proc; 2005 Mar; 37(2):726-8. PubMed ID: 15848514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term improvement of deceased donor renal allograft survival since 1996: a single transplant center study.
    Sola E; Gonzalez-Molina M; Cabello M; Burgos D; Ramos J; Gutierrez C; Lopez V; Soler J; de la Vega E; Hernandez D
    Transplantation; 2010 Mar; 89(6):714-20. PubMed ID: 20035250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Explainable variation in renal transplant outcomes: a comparison of standard and expanded criteria donors.
    Gjertson DW
    Clin Transpl; 2004; ():303-14. PubMed ID: 16704159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding the criteria of renal kidneys for transplantation: use of donors with acute renal failure.
    Deroure B; Kamar N; Depreneuf H; Jacquet A; Francois H; Charpentier B; Rostaing L; Durrbach A
    Nephrol Dial Transplant; 2010 Jun; 25(6):1980-6. PubMed ID: 20167568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of C4d staining with minimal histologic abnormalities.
    Haas M
    Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting complement activation in brain-dead donors improves renal function after transplantation.
    Damman J; Hoeger S; Boneschansker L; Theruvath A; Waldherr R; Leuvenink HG; Ploeg RJ; Yard BA; Seelen MA
    Transpl Immunol; 2011 May; 24(4):233-7. PubMed ID: 21440065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting kidney-transplant outcome in recipients with lupus nephritis.
    Tang H; Chelamcharla M; Baird BC; Shihab FS; Koford JK; Goldfarb-Rumyantzev AS
    Clin Transplant; 2008; 22(3):263-72. PubMed ID: 18482047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.